Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody

September 16, 2020

- Study demonstrated 100% efficacy in prevention of parvovirus infection in proph...

Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth Conference

September 9, 2020

SAN FRANCISCO , Sept. 9, 2020 /PRNewswire/ --  Kindred Biosciences, Inc.  (NASDAQ...

Kindred Biosciences Announces Second Quarter 2020 Financial Results

August 5, 2020

SAN FRANCISCO , Aug. 5, 2020 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ: ...

Kindred Biosciences to Announce Second Quarter 2020 Financial Results

July 23, 2020

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...

Kindred Biosciences Announces Plan to Strengthen its Strategic Position

June 8, 2020

SAN FRANCISCO , June 8, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...

Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart

May 20, 2020

SAN FRANCISCO , May 20, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...

Kindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws Conference

May 13, 2020

SAN FRANCISCO , May 13, 2020 /PRNewswire/ -- Kindred Biosciences , Inc. (NASDAQ: ...

Kindred Biosciences Announces First Quarter 2020 Financial Results

May 7, 2020

SAN FRANCISCO , May 7, 2020 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ: K...

Kindred Biosciences to Announce First Quarter 2020 Financial Results

April 23, 2020

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...

Kindred Biosciences Announces Completion of Mirataz® (mirtazapine transdermal ointment) Transaction

April 15, 2020

SAN FRANCISCO , April 15, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...

Kindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in Dogs

March 24, 2020

SAN FRANCISCO , March 24, 2020 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ...

Kindred Biosciences Announces Mirataz® (mirtazapine transdermal ointment) Transaction and Reports Fourth Quarter and Full Year 2019 Financial Results

March 16, 2020

SAN FRANCISCO , March 16, 2020 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ...

Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial Results

March 3, 2020

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...

Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health Summit

February 18, 2020

SAN FRANCISCO , Feb. 18, 2020 /PRNewswire/ --  Kindred Biosciences, Inc.  (NASDAQ...

Kindred Biosciences Announces Half-Life Extension Technology for Canine Antibodies

January 8, 2020

- Positive results from canine pharmacokinetic study demonstrate up to three-fold...